NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.05 +0.05 (+0.06%) GOLD FUTURES
2,314.70 +3.70 (+0.16%) DOW
38,251.19 +347.90 (+0.92%) Bitcoin GBP
47,193.30 +691.70 (+1.49%)
Smith & Nephew plc (SN.L)
| Previous close | 976.60 |
| Open | 979.20 |
| Bid | 680.00 x 0 |
| Ask | 1,025.00 x 0 |
| Day's range | 976.60 - 990.80 |
| 52-week range | 887.00 - 1,315.00 |
| Volume | |
| Avg. volume | 3,692,058 |
| Market cap | 8.618B |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | 41.07 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.30 (3.10%) |
| Ex-dividend date | 28 Mar 2024 |
| 1y target est | N/A |
- Globe Newswire
Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention
Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research group published in the International Wound Journal,1 that shows a novel mechanism of action relating to pressure injury prevention (PIP). The study found that due to the independent and non-bonded internal layers of ALLEVYN LIFE Dressing, a layer-on-layer sliding phenomenon occurs and allows for dissip
- GlobeNewswire
Smith+Nephew signs exclusive distribution agreement to provide unique NAVBIT SPRINT™ solution in Australia
Compact, single-use, and simple-to-use technology offers surgeons a fast, reliable navigation solution for hip arthroplasty Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announced an agreement with NAVBIT to exclusively distribute the NAVBIT SPRINT™ in Australia during the recent Australian Orthopedics Association COE Meeting in Sydney. A single-use, sterile navigation system with everything provided in a small carton, NAVBIT SPRINT™ is designed to suit busy surgeons -
- GlobeNewswire
Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the review of medical technologies guidance from the UK National Institute for Health and Care Excellence (NICE) for its PICO Single Use Negative Pressure Wound Therapy System (sNPWT). NICE have reviewed ‘Medical Technology Guideline 43 PICO negative pressure wound dressings for closed surgical incisions’ which recognises that Smith+Nephew’s PICO sNPWT provides better clinical outcomes than standard dressings
